^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Title:

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Published date:
04/14/2021
Excerpt:
Recommendations: When cisplatin is contraindicated because of comorbidities, carboplatin plus etoposide is an alternative [II, A].
DOI:
10.1016/j.annonc.2021.03.207